Goldman Sachs Discusses Hill-Rom Holdings

Goldman Sachs is out with a research report on Hill-Rom Holdings, Inc. HRC and it has a Neutral rating on shares. In a note to clients, Goldman Sachs writes, "Hill-Rom currently generates about 3% of revenue from SNF capital sales, and these products typically are lower-tech and lower-margin solutions. Hypothetically, assuming a worst-case scenario (in which the entire Hill-Rom SNF business goes away), our 2012 revenue estimate for the company would decrease by $51 mn. Additionally, we applied a 25% incremental margin on this business, resulting in a $0.14 dilutive effect to our EPS estimate, or roughly a 5.5% reduction. This is less than the sell-off in the shares today." Shares of HRC are down $3.02 to $34.27, a loss of 8.1%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsGoldman SachsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!